Cargando…

Myeloma Bone Disease: A Comprehensive Review

Multiple myeloma (MM) is a neoplastic clonal proliferation of plasma cells in the bone marrow microenvironment, characterized by overproduction of heavy- and light-chain monoclonal proteins (M-protein). These proteins are mainly found in the serum and/or urine. Reduction in normal gammaglobulins (im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukkamalla, Shiva Kumar Reddy, Malipeddi, Dhatri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227693/ https://www.ncbi.nlm.nih.gov/pubmed/34201396 http://dx.doi.org/10.3390/ijms22126208

Ejemplares similares

Bilateral Myelomatous Pleural Effusion in a Patient with IgA Kappa Multiple Myeloma
por: Asiamah, Rebecca, et al.
Publicado: (2017)

Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome
por: Chakraborty, Rajshekhar, et al.
Publicado: (2014)

A case of Hodgkin’s lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD
por: Chakraborty, Rajshekhar, et al.
Publicado: (2015)

Prognostic Impact of Tumor Status, Nodal Status and Tumor Sidedness in Metastatic Colon Cancer
por: Mukkamalla, Shiva Kumar R, et al.
Publicado: (2020)

Combined checkpoint inhibitor therapy causing diabetic ketoacidosis in metastatic melanoma
por: Changizzadeh, Pouyan N., et al.
Publicado: (2017)

The role of bone‐modifying agents in myeloma bone disease
por: Lu, Huifang, et al.
Publicado: (2021)

Myeloma Bone Disease: The Osteoblast in the Spotlight
por: Andrews, Rebecca E., et al.
Publicado: (2021)

Multiple Myeloma Associated Bone Disease
por: Rasch, Stine, et al.
Publicado: (2020)

Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review
por: Ismail, Nor Hayati, et al.
Publicado: (2023)

Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base
por: Mukkamalla, Shiva Kumar R., et al.
Publicado: (2020)

Rapid Progress in Immunotherapies for Multiple Myeloma: An Updated Comprehensive Review
por: Nishida, Hiroko
Publicado: (2021)

Myeloma bone disease: Pathophysiology and management
por: Silbermann, Rebecca, et al.
Publicado: (2013)

Pulmonary hypertension in patients with multiple myeloma: A comprehensive review
por: Maddipati, Veeranna, et al.
Publicado: (2023)

Bone Disease in Multiple Myeloma: Pathophysiology and Management
por: Hameed, Abdul, et al.
Publicado: (2014)

New agents in the Treatment of Myeloma Bone Disease
por: Ring, Elizabeth S., et al.
Publicado: (2017)

Pathogenesis and Treatment of Myeloma-Related Bone Disease
por: Gau, Yuh-Ching, et al.
Publicado: (2022)

Pathophysiology and therapeutic advances in myeloma bone disease
por: Zhang, Fujing, et al.
Publicado: (2022)

Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
por: Teramachi, Jumpei, et al.
Publicado: (2023)

Belantamab Mafodotin to Treat Multiple Myeloma: A Comprehensive Review of Disease, Drug Efficacy and Side Effects
por: Lassiter, Grace, et al.
Publicado: (2021)

Myeloma Bone Disease
por: Sanderson, Ralph D, et al.
Publicado: (2009)

Pathogenesis and treatment of multiple myeloma bone disease
por: Hiasa, Masahiro, et al.
Publicado: (2021)

Cellular Mechanisms of Multiple Myeloma Bone Disease
por: Oranger, Angela, et al.
Publicado: (2013)

Osteoblast suppression in multiple myeloma bone disease
por: Adamik, Juraj, et al.
Publicado: (2018)

Bone Disease in Multiple Myeloma: Biologic and Clinical Implications
por: Bernstein, Zachary S., et al.
Publicado: (2022)

Compound Dorsal Ganglion: A Rare Masquerade of Tuberculosis
por: Mukkamalla, Sai Kumar Reddy, et al.
Publicado: (2022)

Management of Myeloma Bone Lesions
por: Du, Jeng-Shiun, et al.
Publicado: (2021)

Alzheimer’s Disease and Herbal Combination Therapy: A Comprehensive Review
por: Pradeep, Sushma, et al.
Publicado: (2020)

Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies
por: Vallet, Sonia, et al.
Publicado: (2018)

Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology
por: Raimondi, Lavinia, et al.
Publicado: (2020)

Bone Marrow Microenvironment Interplay and Current Clinical Practice in Multiple Myeloma: A Review of the Balkan Myeloma Study Group
por: Bila, Jelena, et al.
Publicado: (2021)

Bone-targeted agents in multiple myeloma
por: Nishida, Hiroko
Publicado: (2018)

Minimally Invasive Interventional Procedures for Metastatic Bone Disease: A Comprehensive Review
por: Papalexis, Nicolas, et al.
Publicado: (2022)

Pathogenic Mechanisms of Myeloma Bone Disease and Possible Roles for NRF2
por: Yen, Chia-Hung, et al.
Publicado: (2020)

The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease
por: Lungu, Oxana, et al.
Publicado: (2023)

Pathogenesis of bone disease in multiple myeloma: from bench to bedside
por: Terpos, Evangelos, et al.
Publicado: (2018)

A Rare Case of Solitary Osteochondroma of Right Hip with Unusual Clinical Presentation
por: Mukkamalla, Sai Kumar Reddy, et al.
Publicado: (2023)

A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics
por: Awada, Hassan, et al.
Publicado: (2021)

Abstract No.: ABS0639: A comparison of the total intraoperative fluid administered by goal directed fluid therapy and conventional fluid therapy in isolated traumatic brain injury patients undergoing early decompressive craniectomy- a prospective randomised controlled trial
por: Jonna, Dhatri
Publicado: (2022)

Multiple Myeloma Bone Disease: Implication of MicroRNAs in Its Molecular Background
por: Papanota, Aristea-Maria, et al.
Publicado: (2021)

Cost-Effective Isolation of a Process Impurity of Pregabalin
por: Prakash, Lakkireddy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f02kbcib0uvjsg62tebn423lff